Log in to save to my catalogue

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_253658

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

About this item

Full title

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

Publisher

United States: John Wiley & Sons, Inc

Journal title

Annals of clinical and translational neurology, 2017-04, Vol.4 (4), p.226-235

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
With an increasing incidence of Alzheimer's disease (AD) and neurodegenerative tauopathies, there is an urgent need to develop reliable biomarkers for the diagnosis and monitoring of the disease, such as the recently discovered toxic tau oligomers. Here, we aimed to demonstrate the presence of tau oligomers in the cerebrospinal fluid (...

Alternative Titles

Full title

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_253658

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_253658

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.382

How to access this item